Evidence map›Paper›PMID 30271884›Full record

ArticleEmerging topics in life sciences2017

Emerging challenges in understanding trypanosome antigenic variation.

Richard McCulloch, Christina A Cobbold, Luisa Figueiredo, Andrew Jackson, Liam J Morrison, Monica R Mugnier, Nina Papavasiliou, Achim Schnaufer, Keith Matthews

Open access · hybridAbstract read
In one paragraph

Article in Emerging topics in life sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Telomere maintenance in African trypanosomes.Frontiers in molecular biosciences · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Regulation of Antigenic Variation byPathogens (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Microorganisms · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Richard McCullochThe Wellcome Centre for Molecular Parasitology, University of Glasgow, 120 University Place, Glasgow, G12 8TA, U.K. Richard.mcculloch@glasgow.ac.uk.
Christina A CobboldSchool of Mathematics and Statistics, University of Glasgow, University Place, Glasgow, G12 8QS,United Kingdom. Christina.Cobbold@glasgow.ac.uk.
Luisa FigueiredoInstituto de Medicina Molecular, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal. lmf@medicina.ulisboa.pt.
Andrew JacksonInstitute of Infection and Global Health, Department of Infection Biology, University of Liverpool, 146 Brownlow Hill, Liverpool, L3 5RF, United Kingdom. a.p.jackson@liv.ac.uk.
Liam J MorrisonThe Roslin Institute, Royal (Dick) School of Veterinary Studies, Division of Infection and Immunity, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, United Kingdom. liam.morrison@roslin.ed.ac.uk.
Monica R MugnierDepartment of Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. mmugnie1@jhu.edu.
Nina PapavasiliouImmune Diversity (D150), Division Immunology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany. n.papavasiliou@dkfz-heidelberg.de.
Achim SchnauferInstitute for Immunology & Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, Charlotte Auerbach Road, Edinburgh, EH9 3FL, United Kingdom. keith.matthews@ed.ac.uk; achim.schnaufer@ed.ac.uk.
Keith MatthewsImmune Diversity (D150), Division Immunology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany. n.papavasiliou@dkfz-heidelberg.de.
German Cancer Research Center · DEInstituto de Medicina Molecular João Lobo AntunesJohns Hopkins University · US

Funding

Variant surface glycoprotein diversification in Trypanosoma bruceiDP5OD023065 · OD · JOHNS HOPKINS UNIVERSITY · PI MUGNIER, MONICA · 2016 to 2020
$2.1M
Biotechnology and Biological Sciences Research Council BB/P004202/1Medical Research Council MR/L019701/1NIH HHS DP5 OD023065
6 · The paper itself

Abstract

Many pathogens evade host immunity by periodically changing the proteins they express on their surface - a phenomenon termed antigenic variation. An extreme form of antigenic variation, based around switching the composition of a Variant Surface Glycoprotein (VSG) coat, is exhibited by the African trypanosome

Identifiers

PMID30271884
PMCPMC6162063
OpenAlexW2778717962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.